Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
tsh [2025/01/28 11:26] – created admin | tsh [2025/01/29 04:39] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
- | Purpose of examination: | + | TSH Examination Procedure |
+ | **1.Purpose of examination: | ||
TSH assay is a Chemiluminescent Microparticle Immunoassay (CMIA) for the quantitative determination of human Thyroid Stimulating Hormone (TSH) in human serum and plasma. | TSH assay is a Chemiluminescent Microparticle Immunoassay (CMIA) for the quantitative determination of human Thyroid Stimulating Hormone (TSH) in human serum and plasma. | ||
- | Responsibility and Authority: | + | **2.Responsibility and Authority:** |
- | ● Calibration: | + | |
- | ● Quality Control: Technician | + | |
- | ● Routine operation: Technician | + | |
- | ● Overall Monitoring: Quality Manager | + | |
- | Sample Details: | + | **3.Sample Details:** |
- | ● Type of Sample: Serum, | + | |
- | ● Type of container and additives: Plain without any additives | + | |
- | ● Patient Preparation: | + | |
- | ● Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | + | |
- | ● Handling and transport: As per Primary Sample collection manual | + | |
- | ● Storage: 24 hours at 2-8° C | + | |
- | Required Equipment: | + | **4.Required Equipment:** |
- | ●Centrifuge, Auto-Pipette, | + | Centrifuge, Auto-Pipette, |
- | Required reagents: | + | **5.Required reagents:** |
- | Microparticles | + | |
- | Conjugate | + | |
- | Multi Assay manual dilution | + | |
- | Pre trigger solution | + | |
- | Trigger solution | + | |
- | Wash-buffer | + | |
- | Reagent Handling | + | **6.Reagent Handling** |
- | ● Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | + | |
- | Reagent Storage and stability | + | |
- | Unopened reagent stable at 15-30°C until expiration date. | + | |
- | On board System temperature reagent is stable for 28 days | + | |
- | Instability or deterioration should be suspected if there are precipitates, | + | |
- | contamination, | + | |
- | Calibration Procedure: | + | **7.Calibration Procedure:** |
- | ●ARCHITECT | + | |
- | ● Frequency: | + | |
- | Reagent lot change | + | |
- | QC out of range | + | |
- | After service or maintenance | + | |
- | Replacement in any parts of Instrument | + | |
- | Procedure: | + | |
- | Start the equipment.WDI abbotte fully.docx | + | |
- | Calibrators are ready to use. | + | |
- | Put calibrator 15-20 minutes at room temperature | + | |
- | Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent foam formation. | + | |
- | Take a 150 µl calibrator solution in to separate aliquots. | + | |
- | Go to the calibration and give the calibration order. | + | |
- | Verify calibration with at least two levels of controls | + | |
- | If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. | + | |
- | Quality control Procedure: | + | **8.Quality control Procedure:** |
Name: Bio Rad Level 1 ,2 & 3 | Name: Bio Rad Level 1 ,2 & 3 | ||
Frequency: As per Quality Control Procedure | Frequency: As per Quality Control Procedure | ||
- | ●Procedure for Reconstitution of IQC | ||
- | Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. | ||
- | Leave to stand for 30 min in the dark place. | ||
- | Swirl gently several times during the reconstitution period to ensure that the contents are completely dissolved. | ||
- | Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. | ||
- | Prepare aliquots of 150 µl from the reconstituted QC material. | ||
- | Store these aliquots at -15° C to -20° C. | ||
- | Prior to use, make sure that aliquots should be at room temperature for at least 15 min. | ||
- | ●Procedure to run IQC | ||
- | Press Control order | ||
- | Select Assay /Panel, to be run. | ||
- | Select the control/s and its level/s | ||
- | Give Carrier Number and Position number | ||
- | Press F3 / Add order | ||
- | Put respected carrier in RSH rack | ||
- | Check IQC results, in case outliers call residents. | ||
- | Principle of the procedure used for examinations: | + | **Procedure for Reconstitution of IQC** |
+ | * Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. | ||
+ | * Leave to stand for 30 min in the dark place. | ||
+ | * Swirl gently several times during the reconstitution period to ensure that the contents are completely dissolved. | ||
+ | * Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. | ||
+ | * Prepare aliquots of 150 µl from the reconstituted QC material. | ||
+ | * Store these aliquots at -15° C to -20° C. | ||
+ | * Prior to use, make sure that aliquots should be at room temperature for at least 15 min. | ||
+ | **Procedure to run IQC** | ||
+ | * Press Control order | ||
+ | * Select Assay /Panel, to be run. | ||
+ | * Select the control/s and its level/s | ||
+ | * Give Carrier Number and Position number | ||
+ | * Press F3 / Add order | ||
+ | * Put respected carrier in RSH rack | ||
+ | * Check IQC results, in case outliers call residents. | ||
+ | |||
+ | **9.Principle of the procedure used for examinations: | ||
The ARCHITECT TSH assay is an automated two-step immunoassay to determine the presence of Thyroid Stimulating Hormone (TSH) in human serum and plasma using CMIA technology with flexible assay protocols, referred to as Chemiflex. | The ARCHITECT TSH assay is an automated two-step immunoassay to determine the presence of Thyroid Stimulating Hormone (TSH) in human serum and plasma using CMIA technology with flexible assay protocols, referred to as Chemiflex. | ||
- | 1. Sample, anti-β TSH antibody coated paramagnetic microparticles and TSH Assay Diluent are combined. TSH present in the sample binds to the anti-TSH antibody coated microparticles. | + | * Sample, anti-β TSH antibody coated paramagnetic microparticles and TSH Assay Diluent are combined. TSH present in the sample binds to the anti-TSH antibody coated microparticles. |
- | 2. After washing, anti-α TSH acridinium-labeled conjugate is added to create a reaction mixture. | + | |
- | 3. Following another wash cycle, Pre-Trigger and Trigger Solutions are added to the reaction mixture. | + | |
- | 4. The resulting chemiluminescent reaction is measured as relative light units (RLUs). There is a direct relationship between the amount of TSH in the sample and the RLUs detected by the | + | |
- | ARCHITECT iSystem optics. | + | |
- | Sample Preparation: | + | **10.Sample Preparation: |
- | ● Required SampleVolume: | + | |
- | ● Temperature: | + | |
Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. | Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. | ||
- | ●Procedure to run Patient sample | + | **Procedure to run Patient sample** |
- | Press Patient order | + | |
- | Select Assay /Panel, to be run. | + | |
- | Give Carrier Number and Position number | + | |
- | Press F3 / Add order | + | |
- | Put respected carrier in RSH rack | + | |
- | Performance Characteristics: | + | **11.Performance Characteristics: |
- | ● Linearity: | + | Linearity: |
- | ● The limit of detection (LOD) : ≤ 0.4 ng/dL. | + | The limit of detection (LOD) : ≤ 0.4 ng/dL. |
- | ● The limit of quantification(LOQ): | + | The limit of quantification(LOQ): |
- | ● Unit:ng/dL. | + | Unit:ng/dL. |
- | Normal and critical ranges: | + | **Normal and critical ranges:** |
- | Thyrotropin (thyroid-stimulating hormone) (TSH) | + | **Thyrotropin (thyroid-stimulating hormone) (TSH)** |
- | Birth-4 d | + | ^Birth-4 d^1.0-39.0^µIU/mL^ |
- | 1.0-39.0 | + | ^2-20 wk^1.7-9.1^µIU/mL^ |
- | µIU/mL | + | ^21 wk-20 y^0.7-6.4^µIU/ |
+ | ^21-54 y^0.4-4.2^µIU/ | ||
+ | ^55-87 y^0.5-8.9^µIU/ | ||
- | + | **12.Laboratory Clinical interpretation: | |
- | 2-20 wk | + | |
- | 1.7-9.1 | + | |
- | µIU/mL | + | |
- | + | ||
- | + | ||
- | 21 wk-20 y | + | |
- | 0.7-6.4 | + | |
- | µIU/mL | + | |
- | + | ||
- | + | ||
- | 21-54 y | + | |
- | 0.4-4.2 | + | |
- | µIU/mL | + | |
- | + | ||
- | + | ||
- | 55-87 y | + | |
- | 0.5-8.9 | + | |
- | µIU/mL | + | |
- | + | ||
- | + | ||
- | Laboratory Clinical interpretation: | + | |
The common causes of High TSH Level are as follows: Hypothyroidism The common causes of LowTSH Level are as follows: | The common causes of High TSH Level are as follows: Hypothyroidism The common causes of LowTSH Level are as follows: | ||
- | Interference and cross reaction: | + | **13.Interference and cross reaction:** |
TSH assay is designed to have a potential interference from hemoglobin, bilirubin, triglycerides and protein of ≤ 10% at the levels indicated below. | TSH assay is designed to have a potential interference from hemoglobin, bilirubin, triglycerides and protein of ≤ 10% at the levels indicated below. | ||
- | Hemoglobin | + | ^Hemoglobin^≤ 500 mg/dL^ |
- | Bilirubin | + | ^Bilirubin^≤ 20 mg/dL^ |
- | Triglycerides | + | ^Triglycerides^≤ 3000 mg/dL^ |
- | Protein | + | ^Protein^≤ 2 g/dL and 12 g/dL^ |
- | Potential source of variation: | + | **14.Potential source of variation:** |
Turn around time (TAT): | Turn around time (TAT): | ||
Routine: 6.0 hours | Routine: 6.0 hours | ||
Urgent: 2.0 hours | Urgent: 2.0 hours | ||
- | Recording of observation: | + | **15.Recording of observation**: |
Software backup | Software backup | ||
Machine raw data | Machine raw data | ||
- | Storage & Disposal of waste: Follow storage & discard procedure | + | |
- | Environmental & Safety control: | + | **16.Storage & Disposal of waste:** Follow storage & discard procedure |
+ | |||
+ | **17.Environmental & Safety control:** | ||
Contact with acids liberates very toxic gas. Dispose of contents / container in accordance with local regulations. | Contact with acids liberates very toxic gas. Dispose of contents / container in accordance with local regulations. | ||
- | References: | + | **18.References:** |
- | Tietz NW, Huang WY, Rauh DF, et al. Laboratory tests in the differential diagnosis of hyperamylasemia. Clin Chem 1986 32(2): | + | |
- | 6 Junge W. Troge B, Klein G, et al. Evaluation of a New Assay for Pancreatic Amylase: Performance Characteristics and Estimation of Reference Intervals Clin Biochem 1989,22 109-114 | + | |
- | Stuttgart/ | + | |
- | 4 Steinberg WM, Goldstein SS, Davies ND, et al. Diagnostic assays in acute pancreatitis [Review]. Ann Intern Med 1985, | + | |
+ | |||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: TSH Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||